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Transthyretin (TTR) is a homotetrameric plasma protein that, as a result of a set of not yet fully characterized conformational changes, forms ®brillar aggregates that are the major protein component of amyloid deposits. More than 80 mutations associated with TTR amyloid deposition have been described in the literature. X-ray crystallography was used to elucidate the three-dimensional structure of two important TTR variants: TTR Y78F, an amyloidogenic protein, and TTR R104H, which is associated with a protective effect over the amyloidogenic V30M mutation. The structures of those two TTR variants have been determined in space group P2 1 2 1 2 to 1.55 and 1.60 A Ê resolution, respectively, using molecularreplacement techniques. Detailed analysis of the protein model for TTR Y78F indicates a destabilization of the contacts between the -helix and AB loop and the body of the molecule, intimately related to the amyloidogenic nature; contrastingly, in the TTR R104H variant new contacts involving the N-terminal region and His104 are clearly antagonists of amyloid formation.
Introduction
Transthyretin (TTR) is a protein found both in the plasma and in the cerebrospinal¯uid that is known to bind thyroxine (L-T4) and retinol-binding protein (RBP). Its relevant biological form is a homotetramer in which each subunit is composed of 127 amino acids. The three-dimensional structure of TTR, as determined by X-ray crystallography (Blake et al., 1978) , shows that each monomer is composed of eight -strands (A±H) that assemble non-covalently in a -sandwich, with strands CBEF facing strands DAGH (Fig. 1) . The single -helical element that is present in each monomer comprises a short segment of seven amino acids located between strands E and F. The dimer, which is the repeating unit in the crystallographic asymmetric unit cell of the wildtype protein and several variants, is composed of one pair of eight-stranded -sandwiches, which are held together through hydrogen bonds between the strands HH H and FF H . The tetramer in the crystallographic structure is formed when two dimers related by a twofold axis associate through contacts between the AB loops of one dimer and the H strands of the other dimer.
Structures of TTR in complex with thyroxine (T4) and RBP have also been determined by X-ray crystallography (Wojtczak, 1996; Monaco et al., 1995) . The extracellular deposition of transthyretin, in the form of ®brillar aggregates characterized by an extensive -sheet structure, has been shown to be associated with senile systemic amyloidosis (SSA) or, more commonly, with familial amyloidotic polyneuropathy (FAP). In the former, the wild-type (WT) protein is the major component of the aggregates, whereas in the latter a variant protein is present (Saraiva, 1996) . Thus far, over 80 amyloidogenic and non-amyloidogenic mutations have been found of TTR (Saraiva, 2001) . There are only a restricted number of nonpathogenic mutations, some of which have been shown to exert a protective effect on heterozygotic individual carriers of an amyloidogenic TTR variant.
In the case of TTR Y78F, the mutation is located in the single -helix present in each monomer. This variant was engineered after careful analysis of the structure of the TTR L55P mutant, which is one of the most aggressive variants described so far and has been reported as being implicated in the early onset of FAP (Jacobson et al., 1992) . The threedimensional structure of TTR suggested that hydrogen bonds between the OH group of Tyr78 and some residues belonging to the AB loop play a key role in the overall fold and stability of the protein (Sebastiao et al., 1998) . In fact, biochemical studies have shown that TTR Y78F is highly prone to ®bril formation in vitro upon acidi®cation (Redondo et al., 2000) . Furthermore, and most interestingly, this variant has been shown to react in its soluble tetrameric form with a monoclonal antibody reported to only recognize structures presenting a highly amyloidogenic nature (Goldsteins et al., 1999) . It is possible that this variant resembles an early intermediate in the ®brillogenesis cascade (Redondo et al., 2000) . Recently, the clinical relevance of the mutation was shown by its identi®cation in families of Italian origin; it has been reported to be causative of peripheral neuropathy, carpal tunnel syndrome, skin amyloidosis (Magy et al., 2003) and also cardiomyopathy (Anesi et al., 2001) .
Only a few of the various mutations of TTR identi®ed to date display non-amyloidogenic effects. Of those, a more restricted group has been associated with a protective effect against the development of the disease in heterozygotic compound carriers of an amyloidogenic mutation. This is the case for the mutation involving an arginine to histidine exchange at position 104 of the TTR amino-acid sequence, which is located in the protein FG loop, and that was originally identi®ed in Japanese heterozygous individuals suffering from FAP (Terazaki et al., 1999) . Individuals carrying this mutation show increased levels of TTR and RBP in the serum, which is in accordance with previous observations for carriers of TTR T119M, another mutation conferring a protective effect in carriers of amyloidogenic TTR V30M. Likewise, TTR V30M/ R104H does not dissociate in its monomeric subunits as easily as the V30M protein, but does however show a T4-binding af®nity that is lower than normal (Almeida et al., 2000) .
The crystal structures of several TTR variants have consistently revealed, with the exceptions of L55P (Sebastiao et al., 1998) and the G53S/E54D/L55S triple mutant , that there are no major structural changes induced upon mutation.
Given the rather poor knowledge oft the structure of TTRamyloid ®brils and the dif®culties encountered in obtaining a model with atomic resolution, an integrated analysis of the structural relevant features of both amyloidogenic and nonamyloidogenic/protective TTR variants should prove crucial to shed some light on the pathway leading to ®brillogenesis. Using X-ray crystallography, we have solved the structures of two variants with opposite clinical outcomes: TTR R104H, a protective mutation with increased T4-binding af®nity, and TTR Y78F, a highly amyloidogenic mutation with a fold in its soluble form that might represent an early intermediate in the ®brillogenesis pathway.
Material and methods

Protein preparation and crystallization
Recombinant TTR R104H and TTR Y78F were isolated and puri®ed as described elsewhere (Almeida et al., 2000; Redondo et al., 2000) . The proteins were crystallized by vapour-diffusion methods after diluting the protein solutions (10 mg ml
À1
) in a 1:1 ratio with the reservoir solutions. Crystals of the recombinant TTR R104H (10 mg ml
) were grown at 293 K using a reservoir solution consisting of 18% PEG 3350, 0.2 M ammonium sulfate and 50 mM sodium acetate pH 5.1. The Y78F TTR variant was crystallized at 287 K with a reservoir solution consisting of 2.0 M ammonium sulfate, 7% glycerol and 0.2 M sodium acetate pH 4.8.
Crystals were sequentially transferred to stabilizing solutions (27% PEG 3350, 0.3 M ammonium sulfate, 0.75 M sodium acetate pH 5.1 for R104H and 2.5 M ammonium (24)1 sulfate, 0.2 M sodium acetate pH 4.8 for Y78F) containing increasing concentrations of glycerol (5±25%) and ®nally cryocooled in liquid nitrogen.
Data collection and processing
X-ray diffraction data were collected at 100 K using synchrotron radiation on beamline ID14-1 at the European Synchrotron Radiation Facility (ESRF) in Grenoble. Diffraction data for both variants were collected on an ADSC Q4R CCD detector from a single crystal (both variants) at a wavelength of 0.934 A Ê . Data were evaluated and processed with MOSFLM (Leslie, 1992) and reduced with SCALA and TRUNCATE (Collaborative Computational Project, Number 4, 1994) . Crystals of recombinant TTR R104H and TTR Y78F diffract to a maximum resolution of 1.54 and 1.55 A Ê , respectively, and both variants belong to space group for TTR R104H. The Matthews coef®cient is 2.1 A Ê 3 Da À1 for both structures.
Structure determination and refinement
The structures were solved by molecular-replacement techniques using AMoRe (Navaza, 1994) and as a search model the coordinates of wild-type TTR (Steinrauf et al., 1993 ; PDB code 1tta) for R104H TTR and the T119M variant (Sebastiao et al., 2001 ; PDB code 1f86) for Y78F TTR. The mutated amino acids were replaced by Ala residues in both search models. Calculations were performed with data in the 15±3.5 A Ê resolution range and both the rotation and translation functions produced correct solutions that were further improved with a ®nal-rigid body re®nement. An R factor of 0.360 and a correlation coef®cient of 0.692 were found for the TTR Y78F variant, whereas in the case of TTR R104H the values were 0.367 and 0.616, respectively.
Model building was performed on a SGI Graphic Workstation using the program TURBO-FRODO (Roussel & Cambillau, 1989) . Positional and individual temperaturefactor re®nement was carried out with CNS (Bru È nger et al., 1998) for both TTR variants. The computed ' A -weighted (2F obs À F calc ) and (F obs À F calc )-type electron-density maps showed the expected positive difference density for the new amino-acid residues introduced by the mutation in each variant. Automated re®nement was alternated with manual ®tting of the model to the electron density. For each round of re®nement, the positions of the crystallographic re®nement-generated water molecules were checked manually. The ®nal isotropically re®ned models of both variants were further re®ned with SHELX97-2 (Sheldrick & Schneider, 1997) in two rounds of 20 conjugate-gradient least-square cycles using isotropic thermal parameters. Structure validation was performed with the programs PROCHECK (Laskowski et al., 1993) and WHAT_CHECK (Hooft et al., 1996) . Dataprocessing and re®nement statistics are outlined in Table 1 . The N-terminal residues 1±8 are not well de®ned in the electron-density maps and are thus missing in the ®nal structures of both TTR variants. Additionally, residue 9 is not well de®ned in monomer B of TTR R104H and in both subunits of the TTR Y78F model. Likewise, the C-terminal residues were excluded from both models owing to their weak electron densities. These include Lys126 and Glu127 in monomer A of the R104H variant and Pro125, Lys126 and Glu127 in monomer B of the R104H variant and in both monomers of TTR Y78F. Residues Cys10 and Ser117 are found in two alternate conformations in monomers A and B, respectively, of TTR R104H.
Results and discussion
TTR Y78F
TTR Y78F crystallizes isomorphously with the WT protein in space group P2 1 2 1 2, with two monomers in the asymmetric unit, from a solution containing predominantly the tetrameric form of the protein. Diffraction data were collected to 1.55 A Ê resolution using synchrotron radiation. Each TTR monomeric subunit is composed of 127 amino acids that could be consistently modelled in both monomers, with the exception of the N-terminal residues 1±9 and the C-terminal residues 125±127. These are highly disordered and lie in regions not de®ned in the electron-density maps.
The Residue 78 of transthyretin is located in the single -helix in each subunit of the homotetrameric protein (Fig. 1) and in the native TTR protein Asp18 of the AB loop establishes an important hydrogen bond to the OH group of Tyr78, ensuring the association of the loop with the body of the molecule (Fig. 2) . Thus, the tyrosine to phenylalanine exchange impairs relevant contacts between the -helix and the AB loop, which is an interface region between the two dimers in the TTR tetramer.
The major differences between the WT and the variant protein are observed in the FG loop, which also differs between monomers A and B. This region has been reported to consistently differ between amyloidogenic variants; however, it shows good similarity between non-amyloidogenic mutants and native TTR (Hamilton et al., 1996) . Nonetheless, it should be noticed that rather poor electron density has been observed in this region of the protein for a number of transthyretin structures determined so far. Subtle differences between WT and Y78F TTR are also observed for the main-chain C atoms belonging to the -helix, mainly those located in the vicinity of the mutated residue. This is explained by the differences in the contacts that residue 78 establishes in the native and in the variant protein. Whereas in the former the tyrosine is hydrogen bonded to Asp18 and, through water bridges, to the main-chain carbonyl O atoms of Pro24 and Ile26, in the Y78F variant the new residue does not allow these contacts to be established (Fig. 2) . Instead, it is slightly tilted towards the indole rings of the neighbouring tryptophan residue and the -helical segment is not so tightly bonded to the core of the molecule. A signi®cant shift in the AB loop of the mutant protein would be predicted, which is not observed in the crystallographic structure. This can be explained by the presence of a water molecule that occupies the cavity left by the removal of the OH group of Tyr78; this favours ef®cient hydrogen bonding to Asp18 and thus stabilizes the loop (Fig. 2) .
Although the helix is not displaced in the structure, the lack of hydrogen bonds may facilitate a putative displacement with consequent exposure of two highly hydrophobic residues, Phe78 and Trp79, to the solvent. The missing contact might favour the formation of a modi®ed structure, highly prone to polymerization, after dissociation of the TTR tetramer. The signi®cance of this contact is further corroborated by the fact that other mutations in the -helix have been found to increase the predisposition of TTR to amyloid formation (Hamilton et al., 1996) and it also has been argued that this is an important site for the initial folding process of TTR (Wilce et al., 1999) .
Recent work has emphasized the important role that nonnative TTR monomeric species formed upon TTR dissociation may play in the ®brillogenesis cascade (Jiang et al., 2001; Quintas et al., 2001; Yang et al., 2003) .
It seems that the displacement of the -helix might be the structural feature in TTR Y78F that leads to the partially unfolded monomers that are the building blocks of the TTR amyloid ®brils. Interestingly, results from molecular-dynamics simulations in TTR monomers showed that the -helix in L55P and V30M TTR suffers large r.m.s.¯uctuations (Yang et al., 2003) .
The reported interaction of the tetrameric soluble form of this variant protein with a monoclonal antibody raised against highly amyloidogenic mutants and amyloid ®brils (Goldsteins et al., 1999) remains unclear since it is not known which region of TTR is recognized by the antibody.
TTR R104H
TTR R104H is a transthyretin mutation that has been described as capable of exerting a protective effect against the development of the disease in compound heterozygotic carriers of the V30M mutation (Terazaki et al., 1999) . Crystals of the recombinant TTR R104H belong to space group P2 1 2 1 2, as is the case for WT TTR, with two monomers in the asymmetric unit. The ®nal re®ned model, which has an R value of 19. 9%, comprises 1841 atoms and 187 water molecules. The Nand C-terminal residues (1±9 and 126±127) are not de®ned in the electron-density maps and were thus excluded from the ®nal A stereoview of a superposition between the WT (in blue) and TTR Y78F (colour-coded with O atoms in red, N atoms in blue and C atoms in yellow) in the region of the mutation. In WT TTR, the hydroxyl group of Tyr78 establishes key contacts with residues in the AB loop, providing a relevant association between two regions located far apart in the protein primary structure. In the Tyr78Phe variant, contacts between the AB loop and the protein core are lost. An additional water molecule ensures near-native hydrogen bonds within the AB-loop region, preventing its complete displacement. The ®nal (2F o À F c ) electron-density map (red, contoured at the 1' level) is shown around Phe78. (24)1 model. The ®nal model has excellent geometry, with no residues in disallowed regions of the Ramachandran plot; 90.3% of amino acids lie in the core region and the remainder in the allowed region.
Again, only subtle differences could be observed between the structures of TTR R104H and WT TTR. Analysis at the dimer±dimer and monomer±monomer interfaces showed no relevant differences from the homologous interaction surfaces in WT TTR. The dissimilarities are also negligible when TTR R104H is compared with TTR T119M, another TTR mutation with protective effects on the development of FAP in carriers of TTR V30M. Residue 104 belongs to the FG loop, which is located on the surface of the transthyretin monomer. This is a region that has been claimed to be involved in amyloid formation, as discrepancies have been observed between several amyloidogenic variants and WT TTR and the nonamyloidogenic A109T variant protein (Hamilton et al., 1996) . The main-chain C atoms of the residues belonging to the FG loop in TTR R104H clearly deviate from the positions adopted in the native TTR structure. However, the contribution of this shift to the non-amyloidogenic behaviour of the protein is dif®cult to interpret since, as previously mentioned, this is a region where the electron density is often poorly de®ned and the different C traces that have been observed may be a result of the protein¯exibility in this region rather than a consistent amyloidogenic feature.
While Arg104 is not well de®ned in WT TTR, the new side chain of the mutated residue, His104, presents different conformations in the two monomers (Table 2 and Fig. 3) . In monomer A it is buried and stacked between Pro11 and Pro125, thus contributing to the stabilization of the C-and N-terminal regions. In monomer B the imidazole ring is hydrogen bonded to the Cys10 main-chain carbonyl. This stabilization effect introduced by the mutation is expected to prevent conformational changes that lead to ®bril formation, indicating that the N-terminal region at the beginning of strand A might be implicated in this process. Recent studies on the formation and structure of TTR amyloid ®brils have suggested that the strands C and D undergo a shift from their native positions and become structurally less de®ned, leaving strands A and B exposed to the solvent (Gales et al., 2003; Olofsson et al., 2004) . Intermonomeric association via strands A/A H and B/B H would drive the formation of a continuous -sheet, providing solvent protection to the otherwise exposed novel edge region (Serag et al., 2002) . In the R104H variant, the new hydrogen bond between His104 and the Cys10 mainchain carbonyl could prevent the hypothesized novel contacts being established by strand A. Characterization of TTR mutants from human serum has revealed extensive posttranslational modi®cations of the Cys10 residue (Theberge et al., 1999) . Of particular importance may be S-sulfonation, which may interact with other regions of the protein through its charged nature. The above-mentioned interaction observed in the TTR R104H protein may hinder access to the side-chain thiol of Cys10 and might thereby prevent generation of some or all of the post-translational modi®cations at Cys10 that may be implicated in amyloidogenesis. As is the case for TTR T119M, the new variant shows an overall increase in the protein stability as a result of the new contacts. The mutation in TTR T119M occurs in the T4-binding channel, whereas in the new TTR R104H variant the mutated residue is located at the protein surface and far from the interaction region. This is in agreement with the observed differences in af®nity for T4 of the two variants (Almeida et al., 2000) . Though both TTR T119M and TTR R104H show an increased T4-binding af®-nity when compared with native TTR, this increase is much larger for TTR T119M, in which closer contacts are established between the protein and the hormone (Sebastiao et al., 2001) . Structural information on the TTR R104H±T4 complex as well as on TTR V30M/R104H is of importance for a more detailed characterization of the features responsible for the bene®cial effects introduced by the mutation on carriers of the amyloidogenic TTR V30M variant.
Comparison of TTR Y78F and TTR R104H models
Since only very small differences were found between the WT protein and each variant, we compared the ®nal re®ned models obtained for TTR Y78F and TTR R104H, which present opposite behaviours in relation to amyloidogenesis. After superimposing both structures, the r.m.s. deviations for the C of each pair of monomers were calculated (Fig. 4) . The Figure 3 A stereoview of the superposition between monomers A (colour coded with O atoms in red, N atoms in blue and C atoms in yellow) and B (green) of R104H TTR around the mutated residue. N-and C-terminal stabilization is observed in monomer A (numbered 10±125), where the mutated residue is buried between Pro11 and Pro125. In monomer B (numbered 1010± 1125) the imidazole ring establishes a hydrogen bond with the Cys10 main-chain carbonyl. highest consistent discrepancies were observed for residues 80±85 in the -helix and its vicinity. Comparison of the B monomers shows another region near residue 100 where a high dissimilarity is observed. However, this corresponds to residues in the FG loop, which, as previously stated, is a highlȳ exible region of the protein. Therefore, these results are in good agreement with the previously discussed differences between the wild-type protein and the TTR Y78F variant. Interestingly, the r.m.s. deviations for the C atoms when monomers of TTR Y78F and TTR T119M are compared show exactly the same pattern (results not shown). These observations give further grounds to the hypothesis that a looser displacement-prone -helix may be the principal culprit for the strong amyloidogenic nature of the TTR Y78F variant. In the case of the R104H TTR, there are no structural displacements in the main-chain region where the mutated residue is located. It seems that the non-amyloidogenic/ protective behaviour of this variant is related to a stabilizing effect arising from the novel contacts introduced by the mutation rather than to a conformational rearrangement leading to a new non-amyloidogenic fold. The strengthening of contacts in critical regions of the protein possibly prevents key structural rearrangements necessary for the ®brillization to occur. On the other hand, the amiloidogenicity of some TTR variants may be related to structural features that help in driving onward the critical steps of the ®brillogenesis cascade.
Conclusions
The exact mechanisms underlying protein deposition in TTRrelated amyloidosis still remain to be elucidated. Nevertheless, a comparative analysis at the molecular level of the native fold and abnormal conformations of different TTR variants has proven to be a valuable tool to characterize the ®brillogenesis cascade.
Here, we have elucidated the structures of two important TTR mutants: TTR Y78F and TTR R104H. While the former strongly suggests a relevant role for the -helix in the overall stability of TTR, the latter showed that N-terminal stabilization might be the key determinant of its protective effects. These results are in good agreement with other insightful data regarding ®bril formation obtained not only by X-ray crystallography but also by various spectroscopy methods (Gales et al., 2003; Olofsson et al., 2004; Serag et al., 2002) .
Hence, it is of great importance to acquire structural data concerning other important TTR variants. This information may give us fruitful insights into other important steps of the complex ®brillogenesis cascade and thus provide us with novel targets for therapeutic intervention.
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